We were at SITC 2018 conference, the most important event in Immunotherapy area. Thousands of scientists and oncologists and biggest pharma discussed the future of Immunotherapies & importance of new breakhrough diagnostics approach. Thanks to our American partner we had a privilage to be invited to this event and our Chief Science Officer took part in that important discussions.
